Answers are grounded in this paper and cite their sources.
Demonstrates enhanced T cell expansion in scaffolds, suggesting improved cancer therapy applications.
T cells are immune cells that are known to be effective at fighting cancer. However, tumour-specific T cell counts are often insufficient to control cancer growths. Adoptive T cell therapy aims to leverage the cancer-killing functions of the immune system by activating and expanding highly effective T cells ex vivo before injecting them into a cancer patient. Recent experimental setups in which T cells are cultured within activating micro-rod scaffolds have achieved significantly improved yields compared with previous methods. There is still much to understand regarding the factors that maximize the expansion of T cells in these scaffolds. In this paper, we present a stochastic agent-based model of T cell expansion alongside its continuum limit to simulate the average interactions between T cells and micro-rods. Our numerical simulations demonstrate that expansion is driven by activated T cells concentrated around micro-rods. Activation is initially fastest in scaffolds with homogeneous micro-rod concentrations, and our results suggest that rapid expansion could be further supported by the gradual movement of micro-rods and cells into heterogeneous clusters. Our simulations reveal that loading the T cell growth factor interleukin-2 into micro-rods significantly prolongs expansion compared with the conventional method of supplementing interleukin-2 into the culture medium.
No takes yet. Share an insight, caveat, or question.
Lacy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: